GJA1 and atrial fibrillation: In a study by Bikou et al., Cx43 was linked to the pathophysiology of AF (previously discussed in relation to Adams et al. study [20] and gene therapy targeting this protein was demonstrated in vivo to hold potential for prevention of atrial arrhythmias [74].